Price loading...

The 2025-2030 World Outlook for Oncolytic Virus Immunotherapies

Price data last checked 90 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
12 May 2024

Similar Products You Might Like

The 2025-2030 World Outlook for RNA-Based Therapeutics and Vaccines
97% match

The 2025-2030 World Outlook for RNA-Based Therapeutics and Vaccines

Out of Stock 23 Jan 2026
The 2025-2030 World Outlook for Therapeutic Cancer Vaccines
97% match

The 2025-2030 World Outlook for Therapeutic Cancer Vaccines

Out of Stock 26 Jan 2026
The 2025-2030 World Outlook for Hospital Infection Therapeutics
96% match

The 2025-2030 World Outlook for Hospital Infection Therapeutics

Out of Stock 31 Jan 2026
The 2025-2030 World Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs
96% match

The 2025-2030 World Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs

Out of Stock 31 Jan 2026
The 2025-2030 World Outlook for Interventional Oncology
96% match

The 2025-2030 World Outlook for Interventional Oncology

Out of Stock 31 Jan 2026
The 2025-2030 World Outlook for Generic Antiviral Drugs
96% match

The 2025-2030 World Outlook for Generic Antiviral Drugs

Out of Stock 31 Jan 2026
The 2025-2030 World Outlook for Cancer Vaccines
96% match

The 2025-2030 World Outlook for Cancer Vaccines

Out of Stock 26 Jan 2026
The 2025-2030 World Outlook for RNA Therapeutics
96% match

The 2025-2030 World Outlook for RNA Therapeutics

Out of Stock 31 Jan 2026
The 2025-2030 World Outlook for Vaccines Sales
96% match

The 2025-2030 World Outlook for Vaccines Sales

Out of Stock 24 Jan 2026
The 2025-2030 World Outlook for Antibody Drug Conjugates
96% match

The 2025-2030 World Outlook for Antibody Drug Conjugates

Out of Stock 11 Jan 2026
The 2025-2030 World Outlook for Therapeutics Proteins
96% match

The 2025-2030 World Outlook for Therapeutics Proteins

Out of Stock 27 Jan 2026
The 2025-2030 World Outlook for Hepatitis C Therapies
96% match

The 2025-2030 World Outlook for Hepatitis C Therapies

Out of Stock 22 Jan 2026
The 2025-2030 World Outlook for Hepatitis C Therapeutics
96% match

The 2025-2030 World Outlook for Hepatitis C Therapeutics

Out of Stock 27 Jan 2026
The 2025-2030 World Outlook for RNA-Based Therapeutics
96% match

The 2025-2030 World Outlook for RNA-Based Therapeutics

Out of Stock 29 Jan 2026
The 2025-2030 World Outlook for Advanced Therapy Medicinal Products
96% match

The 2025-2030 World Outlook for Advanced Therapy Medicinal Products

Out of Stock 23 Jan 2026
The 2025-2030 World Outlook for T-Cell Immunotherapies
96% match

The 2025-2030 World Outlook for T-Cell Immunotherapies

£790.00 31 Jan 2026
The 2025-2030 World Outlook for Generics in Antivirals
96% match

The 2025-2030 World Outlook for Generics in Antivirals

Out of Stock 01 Feb 2026
The 2025-2030 World Outlook for Cancer Therapies
96% match

The 2025-2030 World Outlook for Cancer Therapies

Out of Stock 22 Jan 2026
The 2025-2030 World Outlook for Tumor-Specific Antigen
96% match

The 2025-2030 World Outlook for Tumor-Specific Antigen

Out of Stock 31 Jan 2026
The 2025-2030 World Outlook for Intravenous Therapy and Vein Access
96% match

The 2025-2030 World Outlook for Intravenous Therapy and Vein Access

Out of Stock 25 Jan 2026
The 2025-2030 World Outlook for Herpes Simplex Virus Treatments
96% match

The 2025-2030 World Outlook for Herpes Simplex Virus Treatments

Out of Stock 14 Jan 2026
The 2025-2030 World Outlook for Ultraviolet Germicidal Irradiation
96% match

The 2025-2030 World Outlook for Ultraviolet Germicidal Irradiation

Out of Stock 17 Apr 2026
The 2025-2030 World Outlook for Mono Hepatitis B Vaccines
96% match

The 2025-2030 World Outlook for Mono Hepatitis B Vaccines

Out of Stock 12 Jan 2026
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
96% match

The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products

Out of Stock 14 Jan 2026